Major shareholder announcement

In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co has increased its holding of B shares in Novozymes to 5.10%, previously reported at 4.999% in company announcement no. 36, July 2016.


Baillie Gifford & Co now holds B shares in Novozymes A/S to a total of 15,798,286 shares of a nominal value of DKK 31,596,572, equivalent to 5.10% of Novozymes A/S’ share capital and 1.99% of the voting rights.


Attachments

2016_51_Major Shareholder Announcement_EN.pdf